Metabolic effects of reduced growth hormone action in fatty liver disease.

导出 OA

翻译打印收藏纠错

作者： Kerstin,Rufinatscha ^[1] ; Claudia,Ress ^[2] ; Sabrina,Folie ^[3] ; Simone,Haas ^[1] ; Karin,Salzmann ^[2] ; Patrizia,Moser ^[1] ; Jochen,Dobner ^[2] ; Guenter,Weiss ^[1] ; Paula,Iruzubieta ^[2] ; María Teresa,Arias-Loste ^[1] ; Javier,Crespo ^[2] ; Herbert,Tilg ^[4] ; Susanne,Kaser ^[2]

作者单位： Department of Internal Medicine I, Medical University Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria. ^[1] Christian Doppler Laboratory for Metabolic Crosstalk, Department of Internal Medicine I, Medical University Innsbruck, Innsbruck, Austria. ^[2] Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital, Heinrich-Heine University, Düsseldorf, Germany. ^[3] Institute of Pathology, Medical University Innsbruck, Innsbruck, Austria. ^[4] Institute of Physical Biology, University of Düsseldorf, Düsseldorf, Germany. ^[5] Department of Internal Medicine II, Medical University Innsbruck, Innsbruck, Austria. ^[6] Gastroenterology and Hepatology Unit, Hospital Universitario Marqués de Valdecilla, Instituto de Investigación Valdecilla (IDIVAL), Valdecilla, Spain. ^[7] Facultad de Medicina, Universidad de Cantabria, Santander, Spain. ^[8] Department of Internal Medicine I, Medical University Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria. susanne.kaser@i-med.ac.at. ^[9] Christian Doppler Laboratory for Metabolic Crosstalk, Department of Internal Medicine I, Medical University Innsbruck, Innsbruck, Austria. susanne.kaser@i-med.ac.at. ^[10]

关键词 Growth hormone receptor Insulin signaling NASH obesity